December 4, 2025
All News
December 4, 2025
NRG Oncology seeks to fill the position of Vice Chair of the Ancillary Projects Committee
Read MoreNovember 24, 2025
NRG Oncology Adds New Leadership Members to Developmental Therapeutics, Patient Centered Outcomes Research, Protocol Operations Management, Head and Neck Cancer, and Translational Science Committees
Read MoreNovember 13, 2025
Good Clinical Practices: The Pillars of Protocol Compliance and Patient Safety
Read MoreNovember 13, 2025
NRG Oncology Trial of Sentinel Lymph Node Biopsy for Patients with Early-Stage Oral Cavity Cancer Re-opens to Phase III (NRG-HN006)
Read MoreNovember 13, 2025
Adding Stereotactic Body Radiation Therapy to Immunotherapy-Based Systemic Treatment for Advanced Liver Cancer (NRG-GI012, the “HELIO-RT” Study)
Read MoreNovember 13, 2025
Advocating for Caregivers During National Family Caregiver Awareness Month
Read MoreNovember 13, 2025
Patient Reported Outcomes – Compliance Improvement Semi-Annual Recognition
Read MoreNovember 13, 2025
From PILOT Project to Completed Trial: NRG-CC007CD Results Convey Importance of Survivorship Care Planning for Patients with Prostate Cancer
Read MoreNovember 13, 2025
Highlights from the Advanced Practice Practitioner (APP) Symposium at the NRG Oncology 2025 Summer Meeting
Read MoreNovember 13, 2025
Combining Radiotherapy and Immunotherapy in Patients with Extensive Stage Small Cell Lung Cancer (NRG-LU007, “the RAPTOR Trial”)
Read MoreOctober 29, 2025
NRG Oncology Adds New Leadership Members to Ancillary Projects, Brain Tumor, Breast Cancer, and Patient Advocate Committees
Read MoreOctober 14, 2025
ComboMATCH EAY191-N5 is Accruing Patients with Recurrent or Persistent HER2+ Gynecologic Cancers and Other Solid Tumors
Read MoreOctober 14, 2025
The Latest Updates in Translational Science at NRG Oncology (October 2025)
Read MoreOctober 14, 2025